Procter & Gamble Form 144 Discloses 4,739-Share Sale via Morgan Stanley

Rhea-AI Filing Summary

Form 144 filing for Procter & Gamble (PG). An insider proposes to sell 4,739 shares of Common Stock through Morgan Stanley Smith Barney on 10/02/2025, with an aggregate market value of $720,825.60. The securities were acquired as a Restricted Stock Unit award on 10/03/2022 (9,750 units originally granted). The filer previously sold 13,039 shares on 08/19/2025 for gross proceeds of $2,050,693.08. The filing includes the standard representation that the signer is not aware of undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Small, routine insider sale under Rule 144; not material to company valuation.

The filing reports a planned sale of 4,739 shares by an insider via a brokerage on 10/02/2025. Relative to the issuer's reported outstanding shares (2,342,371,488), the planned sale is immaterial and consistent with routine liquidity by an executive or other insider from prior RSU awards. The notice also discloses a recent sale of 13,039 shares on 08/19/2025, suggesting the filer is monetizing vested equity over time rather than signaling a single large disposition.

Corporate Governance Expert

TL;DR: Compliance-focused filing; contains customary Rule 144 attestations and transaction details.

The notice specifies acquisition as a Restricted Stock Unit award and provides requisite transaction dates, broker details, and prior three-month sales, meeting Rule 144 reporting requirements. There is no mention of any undisclosed material information and no indication of atypical transfer arrangements or contingent consideration. From a governance perspective, the form appears complete for its purpose.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 38th Floor New York NY 10004	4739	720825.60	2342371488	10/02/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	10/03/2022	Restricted Stock Unit Award	The Procter & Gamble Company			9750	10/03/2022	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Shailesh Jejurikar 1 Procter & Gamble Plaza Cincinnati OH 45202	Common Stock	08/19/2025	13039	2050693.08

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for PG report?

The Form 144 reports a proposed sale of 4,739 shares of Procter & Gamble common stock with aggregate market value of $720,825.60 to be executed on 10/02/2025.

Who is the broker handling the sale in the Form 144 for PG?

The broker listed is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 38th Floor, New York, NY 10004.

How and when were the securities being sold acquired according to the filing?

The securities were acquired as a Restricted Stock Unit award from The Procter & Gamble Company on 10/03/2022; the award size shown is 9,750 units.

Did the filer sell any PG shares recently prior to this Form 144?

Yes. The filing discloses a sale of 13,039 shares on 08/19/2025 for gross proceeds of $2,050,693.08 by Shailesh Jejurikar.

Is there any statement about undisclosed material information in the filing?

Yes. The filer signs the standard representation that they do not know of any material adverse information about the issuer that has not been publicly disclosed.